Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial
| Autor: | Lisa B. Cohen, Wen-Chih Wu, Joanna Musial, Lisa Tokuda, Fred Uhrle, Tracey H. Taveira, Sean M. Jeffery, Lan Jiang |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Health Care Providers Cost-Benefit Analysis Psychological intervention lcsh:Medicine Blood Pressure Comorbidity Type 2 diabetes 030204 cardiovascular system & hematology Pharmacists Vascular Medicine Biochemistry law.invention Endocrinology 0302 clinical medicine Randomized controlled trial law Outpatients Health care Medicine and Health Sciences Diabetes diagnosis and management Ambulatory Care Medical Personnel 030212 general & internal medicine lcsh:Science Allied Health Care Professionals Multidisciplinary Middle Aged Professions Female Research Article medicine.medical_specialty HbA1c Patients Endocrine Disorders Hospitals Veterans Cardiology Pharmacist 03 medical and health sciences Diabetes Mellitus medicine Humans Hemoglobin Primary Care Aged Biology and life sciences Primary Health Care business.industry lcsh:R Proteins Patient Acceptance of Health Care medicine.disease Diagnostic medicine United States Health Care Clinical trial Blood pressure Diabetes Mellitus Type 2 Metabolic Disorders Pharmaceutical Services People and Places Physical therapy lcsh:Q Population Groupings business |
| Zdroj: | PLoS ONE PLoS ONE, Vol 13, Iss 4, p e0195898 (2018) |
| ISSN: | 1932-6203 |
| Popis: | Objectives The effectiveness and costs associated with addition of pharmacist-led group medical visits to standard care for patients with Type-2 Diabetes Mellitus (T2DM) is unknown. Methods Randomized-controlled-trial in three US Veteran Health Administration (VHA) Hospitals, where 250 patients with T2DM, HbA1c >7% and either hypertension, active smoking or hyperlipidemia were randomized to either (1) addition of pharmacist-led group-medical-visits or (2) standard care alone for 13 months. Group (4–6 patients) visits consisted of 2-hour, education and comprehensive medication management sessions once weekly for 4 weeks, followed by quarterly visits. Change from baseline in cardiovascular risk estimated by the UKPDS-risk-score, health-related quality-of-life (SF36v) and institutional healthcare costs were compared between study arms. Results After 13 months, both groups had similar and significant improvements from baseline in UKPDS-risk-score (-0.02 ±0.09 and -0.04 ±0.09, group visit and standard care respectively, adjusted p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|